The Trump administration May 5 issued two executive orders on pharmaceutical manufacturing and life-sciences research.

The Food and Drug Administration should look for ways to streamline regulations on new U.S. drug manufacturing facilities to ...

President Trump signs an executive order to boost U.S. drug manufacturing, reducing reliance on foreign producers and ...

This set of revisions would significantly shrink the Federal Acquisition Regulation, as well as empower contracting officers ...

President Donald Trump could sign a sweeping executive order banning gain-of-function research — research that makes viruses more dangerous in ...

FDA Commissioner Marty Makary’s proposal to roll out a new drug approval pathway is heightening hope for the rare disease ...

New export orders fell to the lowest since December 2022 and recorded the biggest drop since April that year, when Shanghai entered a citywide pandemic lockdown. Trump also praised some statements ...

President Donald Trump has signed an executive order designed to overhaul the way the United States produces and oversees its ...